News
Published: Wednesday, May 16, 2012
The Western New York Flash of the Women’s Professional Soccer League Elite (WPSL) is proud to announce IMMCO Diagnostics as their exclusive jersey front sponsor for the 2012 season.
Published: Friday, May 4, 2012
The story published in the May 4th Issue focuses on Immco’s growth on the Buffalo Niagara Medical Campus and its plans for manufacturing expansion.
Published: Wednesday, April 4, 2012
Immco Diagnostics, a worldwide leader in autoimmune diagnostic products and services, will be exhibiting at the upcoming Northeast Region Medical Hospital POCT Laboratory Conference, April 10th in Boxborough, MA.
Published: Monday, January 30, 2012
Immco Diagnostics will have a strong presence at the 8th International Congress on Autoimmunity which will be held in Granada, Spain on May 9-13th, 2012.
Published: Sunday, January 29, 2012
The Buffalo News story published on 1/29/12, highlights the Buffalo Niagara region emerging as a major biotech hub.
Published: Wednesday, January 25, 2012
Immco will be supporting the Center for Immunotherapy at Roswell Park Cancer Institute, which recently announced it has launched a phase I clinical research study of a dendritic cell vaccine designed to both eradicate cancer cells and prevent disease relapse.
Published: Tuesday, January 17, 2012
On February 5, 2012, Immco Diagnostics’ Dr. Lakshmanan Suresh, Assistant Vice President of Laboratory Services, will be speaking at DiaSorin Israel’s “Workshop on Autoimmune Diseases” with Professor Yehuda Shoenfeld, MD, FRCP of the Zabludowicz Center for Autoimmune Diseases at the Sheba Medical Center
Published: Tuesday, January 3, 2012
IMMCO Diagnostics would like to wish all of our distributor partners and customers a happy and healthy New Year.
Published: Thursday, December 22, 2011
IMMCO Diagnostics’ Kishore Malyavantham, Ph.D., Director of Science and Technology, spoke at the “China Autoimmune Liver Conference” held in Beijing last month.
Published: Tuesday, December 20, 2011
IMMCO Diagnostics’ oxLDL ELISA kit was recently used in used in a cutting edge study on acute coronary syndrome (ACS). IMMCO’s oxLDL ELISA was evaluated the prognostic value of IgG anti-oxLDL antibodies and the relationship with statin therapy in patients with ACS.
Published: Thursday, December 8, 2011
IMMCO Diagnostics was awarded $1,050,000 from New York State to fund research and development and continued capital expansion. The research funding will support the development of new diagnostic tests for autoimmune disease and further advance the development of immunogenetic testing.
Published: Friday, November 25, 2011
IMMCO Diagnostics’ was pleased to have exhibited at MEDICA again in 2011. Held in Düsseldorf, Germany, MEDICA is the largest international trade fair for medical technology, lab equipment, diagnostics and pharmaceuticals.
Published: Friday, November 18, 2011
IMMCO Diagnostics’ President and CEO was named to the board of directors of MedTech, an Upstate New York bioscience and medical technology industry association. “This is not only a tremendous opportunity to represent IMMCO, but more importantly project the Upstate New York’s life science technology to the world”, said Maggio.
Published: Tuesday, November 1, 2011
Immco Diagnostics is pleased to announce the introduction of a proprietary
technology and format for detection of 68kD antibodies to a 68kD heat shock
protein associated with sensorineural hearing loss (SNHL). New
ImmcoStripe™ hsp-70 Antibody LIA assay is the first in a series of new LIAs
developed by Immco which will be rolled out in the next 5 months. Other
assays to come include: ImmcoStripe™ Myositis, ANA, Liver, and Gastro, all
in the LIA format.
Published: Wednesday, September 28, 2011
Immco Diagnostics, a worldwide leader in autoimmune diagnostic products and services, In collaboration with the University of Buffalo, presented two scientific posters at the 11th International Sjögren’s Syndrome Conference in Athens, Greece. Researchers identified novel markers for diagnosing Sjögren’s syndrome which will increase the sensitivity and specificity of the diagnosis by up to 25%.
Published: Wednesday, September 14, 2011
September 14 2011, BUFFALO, NY – Celebrating 40 years in oral pathology, Immco Diagnostics was a key exhibitor featured in the “Exhibitor Spotlight” to the grand hall of the Pennsylvania Convention Center in Philadelphia at the 93rd annual meeting of the American Association of Oral and Maxillofacial Surgeons. Immco exhibited a new banner, “Leadership in Oral Pathology” at its booth and presented.
Published: Thursday, August 18, 2011
Immco Diagnostics, a worldwide leader in autoimmune diagnostic products and services, is pleased to sponsor this year’s Hospice Foundation event held on August 18, 2011 at The Acqua on Niagara Street in Buffalo, New York.
Published: Monday, August 15, 2011
Immco Diagnostics, a worldwide leader in autoimmune diagnostic products and services, showcased new instruments at the 24th annual meeting of the Association of Medical Laboratory Immunologists in San Diego. Immco Diagnostics provides a range of instrument platforms to meet the changing needs of the laboratory. In addition to the 3 new Zenit instruments demonstrated at AMLI. Immco also distributes the Mago 4® and 4S®, the DSX™ and DS2™, and instruments by DAS including the AP16 IF Plus, AP22 Speedy IF and AP22 IF Blot.
Published: Thursday, July 28, 2011
Immco Diagnostics, a worldwide leader in autoimmune diagnostic products and services, introduced 3 new instruments at the Clinical Lab Expo at AACC in Atlanta. A pioneer in IFA and ELISA assays for over 40 years, Immco demonstrated how a new range of leading edge instruments is compatible in any size laboratory. As laboratories grow and change, Immco Diagnostics provides the ideal instrument solution based upon laboratory objectives, throughput, technology, size and cost parameters.
Published: Friday, May 27, 2011
Immco Diagnostics Announces 40 Years of Leadership in Autoimmunuity With New Product Catalog
Published: Thursday, March 24, 2011
Immco Diagnostics Opens New Laboratory At Innovation Center on the
Buffalo Niagara Medical Campus
Published: Monday, February 21, 2011
Immco Diagnostics Opens New Laboratory In Innovation Center on the
Buffalo Niagara Medical Campus.
Published: Wednesday, December 15, 2010
BNE is a nonprofit, private business development organization focused on promoting the Buffalo Niagara region as an ideal place for businesses to locate. This month BNE interviews Bill Maggio, President and CEO of Immco in its monthly Buffalo Niagara Life Sciences newsletter. Click headline to link to full article.
Published: Monday, December 13, 2010
Immco’s UNYLAB announces the availability of a new test for transplant patients, ImmuKnow® Cylex® Immune Cell Function Assay. Immco’s UNYLAB is one of a few select labs in New York State validated and approved to conduct this test.
Published: Thursday, November 4, 2010
Empire State Development announces new funding to build out Innovation Center on Buffalo Niagara Medical Campus.
Published: Monday, November 1, 2010
Immco Diagnostics, Inc., a worldwide leader in autoimmune diagnostic products and services, announces the opening of a new facility in the Buffalo Niagara Medical Campus.
Published: Wednesday, September 15, 2010
Immco Diagnostics, Inc. Announces Non Exclusive Agreement with Eurospital to Manufacture Tissue Transglutaminase (tTG)
Published: Tuesday, September 14, 2010
Immco Diagnostics is pleased to announce Dr. Neiders has joined IMMCO Reference Laboratory, specializing in diagnostic immunology and oral pathology.
Published: Friday, July 30, 2010
Immco Diagnostics debuted its new trade show booth at the world’s largest exhibition of clinical laboratory products and services July 27-29 in Anaheim, CA.
Published: Monday, July 12, 2010
We are pleased to announce the new website for our company: www.immco.com.
Published: Thursday, July 8, 2010
Immco’s Reference Laboratory is pleased to announce the addition of three new serology based tests for diagnosing rheumatoid arthritis, graft thrombosis, and antiphospholipid syndrome.
Published: Sunday, January 10, 2010
The Buffalo News - Immco Diagnostics Names William J. Maggio CEO
Published: Friday, October 23, 2009
Buffalo Business First- Immco Diagnostics’ Rajnish Mittal Named CFO of The Year
Published: Monday, October 2, 2006
Immco is pleased to announce the availability of a new anti-CCP test as part of our Rheumatoid Arthritis (RA) panel.